Dissociable Effects of Selective 5-HT2A and 5-HT2C Receptor Antagonists on Serial Spatial Reversal Learning in Rats

被引:0
作者
Vasileios Boulougouris
Jeffrey C Glennon
Trevor W Robbins
机构
[1] Behavioural and Clinical Neuroscience Institute,Department of Experimental Psychology
[2] University of Cambridge,Department of Chemistry
[3] Solvay Pharmaceuticals Research Laboratories,undefined
[4] National University of Ireland Maynooth,undefined
[5] Maynooth,undefined
来源
Neuropsychopharmacology | 2008年 / 33卷
关键词
5-HT; receptor; 5-HT; receptor; spatial reversal learning; perseveration; disinhibition; obsessive-compulsive disorder;
D O I
暂无
中图分类号
学科分类号
摘要
Serotonin (5-hydroxytryptamine, or 5-HT) is strongly implicated in the ability to shift behavior in response to changing stimulus-reward contingencies. However, there is little information on the contribution of different 5-HT receptors in reversal learning. Thus, we investigated the effects of systemic administration of the 5-HT2A antagonist M100907 (0, 0.01, 0.03, and 0.1 mg/kg, i.p.) and the 5-HT2C antagonist SB 242084 (0, 0.1, 0.3, and 1.0 mg/kg, i.p.) on the performance of an instrumental two-lever spatial discrimination and serial spatial reversal learning task, where both levers were presented and only one was reinforced. The rat was required to respond on the reinforced lever under a fixed ratio 3 schedule of reinforcement. Following attainment of criterion, a series of within-session reversals was presented. Neither M100907 nor SB 242084 altered performance during spatial discrimination and retention of the previously reinforced contingencies. M100907 significantly impaired reversal learning by increasing both trials to criterion (only at the highest dose) and incorrect responses to criterion in Reversal 1, a pattern of behavior manifested as increased perseverative responding on the previously reinforced lever. In contrast, SB 242084 improved reversal learning by decreasing trials and incorrect responses to criterion in Reversal 1, with significantly fewer perseverative responses. These data support the view that 5-HT2A and 5-HT2C receptors have distinct roles in cognitive flexibility and response inhibition. The improved performance in reversal learning observed following 5-HT2C receptor antagonism suggests these receptors may offer the potential for therapeutic advances in a number of neuropsychiatric disorders where cognitive deficits are a feature, including obsessive-compulsive disorder.
引用
收藏
页码:2007 / 2019
页数:12
相关论文
共 398 条
[1]  
Abramowski D(1995)Localization of the 5-hydroxytryptamine2C receptor protein in human and rat brain using specific antisera Neuropharmacology 34 1635-1645
[2]  
Rigo M(1994)Constitutively active 5-hydroxytryptamine2C receptors reveal novel inverse agonist activity of receptor ligands J Biol Chem 269 833-835
[3]  
Duc D(1990)The effects of ondansetron, a 5-HT3 receptor antagonist, on cognition in rodents and primates Pharmacol Biochem Behav 35 955-962
[4]  
Hoyer D(1999)A review of central 5-HT receptors and their function Neuropharmacology 38 1083-1152
[5]  
Staufenbiel M(1998)Role of serotonin in obsessive-compulsive disorder Br J Psychiatry 35 13-20
[6]  
Barker EL(2004)Free operant and discrete trial performance of mice in the nine-hole box apparatus: validation using amphetamine and scopolamine Psychopharmacology 174 396-405
[7]  
Westphal RS(1994)Signal transduction differences between 5-hydroxytryptamine type 2A and type 2C receptor systems Mol Pharmacol 46 477-484
[8]  
Schmidt D(1998)Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus Mol Pharmacol 54 94-104
[9]  
Sanders-Bush E(2000)Medial frontal cortex mediates perceptual attentional set shifting in the rat J Neurosci 20 4320-4324
[10]  
Barnes JM(2002)SR46349-B, a 5-HT(2A/2C) receptor antagonist, potentiates haloperidol-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens Neuropsychopharmacology 27 430-441